Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Cassava Shareholder Alert
05:54pm, Thursday, 30'th Sep 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cassava To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co
New York, New York--(Newsfile Corp. - September 30, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Cassava Sciences, Inc. (NA
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
02:43pm, Thursday, 30'th Sep 2021
New York, New York--(Newsfile Corp. - September 30, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cassava Scien
New York, New York--(Newsfile Corp. - September 30, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA)
New York, New York--(Newsfile Corp. - September 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
Pomerantz Law Firm Announces the Filing of a Class Action Against Cassava Sciences, Inc. and Certain Officers - SAVA
08:43pm, Wednesday, 29'th Sep 2021
NEW YORK, Sept. 29, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA) and certain of i
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VIEW, SAVA and HNST
05:10pm, Wednesday, 29'th Sep 2021
NEW YORK, NY / ACCESSWIRE / September 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to par
Philadelphia, Pennsylvania--(Newsfile Corp. - September 29, 2021) - Berger Montague is investigating securities fraud allegations against Cassava Sciences Inc. ("Cassava" or the "Company"). The Firm
Cassava Sciences' Simufilam Could Be Approved Before The End Of 2022
10:47am, Wednesday, 29'th Sep 2021
Cassava Sciences Alzheimer's treatment has proven to not only slow down but also reverse cognition degeneration in Alzheimer's patients leaving the door open for early approval. Concerns existed on a
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
10:42am, Wednesday, 29'th Sep 2021
New York, New York--(Newsfile Corp. - September 29, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cassava Scien
New York, New York--(Newsfile Corp. - September 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAV
New York, New York--(Newsfile Corp. - September 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
New York, New York--(Newsfile Corp. - September 28, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a
RADNOR, Pa., Sept. 28, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces to investors that a securities fraud class action lawsuit has been filed against Cassava Scienc
San Francisco, California--(Newsfile Corp. - September 28, 2021) - Hagens Berman urges Cassava Sciences, Inc. (NASDAQ: SAVA) investors with significant losses to submit your losses now. Class Period:
